Home Insights Due Diligence Essential in Selecting CMO Due Diligence Essential in Selecting CMO June 1, 2010 June 1, 2010 (Vol. 30, No. 11) Firms Must Look Beyond Credentials to Find the Right Partner for Their Manufacturing Needs InsightsBiomanufacturingGenetic Engineering and BiotechnologyNanoparticlesNanotechnologyTechnology and Computational Biology Also of Interest Robots and AI: The Future of Cell and Gene Therapy Manufacturing StockWatch: CDMOs Tumble as Congress Takes Aim at Chinese Biotechs Lonza to Buy Genentech's Vacaville, CA Biologics Manufacturing Site for $1.2B M5 Modulator Enables Tailored Monoclonal Antibody Glycosylation Integrating Bioprocessing with Microfluidics GTC 2024: Nvidia’s Quantum Expansion Runs through the Cloud Related Media Boston and Bioprocessing: GEN Reports Live from the First Day at BPI Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning Excitement in Oakland: A Report from SynBioBeta Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Breathing Oxygen Back into the Biological Conversation Global Single-Use Network Support Assurance of Supply Related Content Robots and AI: The Future of Cell and Gene Therapy Manufacturing StockWatch: CDMOs Tumble as Congress Takes Aim at Chinese Biotechs Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B M5 Modulator Enables Tailored Monoclonal Antibody Glycosylation